Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

2 Brilliant Stocks to Buy With $200 and Hold for 5 Yearsfool.com
Via The Motley Fool · May 14, 2025
ARM Shares Initially Tumbled on Outlook Before Rallying. Is It Time to Buy the Stock?fool.com
Via The Motley Fool · May 14, 2025
Prediction: Trump's China and U.K. Trade Deals Won't Set the Stage for a Lasting Stock Market Rallyfool.com
Via The Motley Fool · May 14, 2025
2 Fintech Growth Stocks to Buy With $200 and Hold Foreverfool.com
Via The Motley Fool · May 14, 2025
Warren Buffett Said Apple CEO Tim Cook Has Made Berkshire Hathaway More Money Than He Has: Was He Right?fool.com
Via The Motley Fool · May 14, 2025
Spousal Social Security Benefits: 3 Things Married Couples Must Know in Retirementfool.com
Via The Motley Fool · May 14, 2025
3 Top Dividend Stocks Yielding Over 3% to Buy Before They Soarfool.com
Via The Motley Fool · May 14, 2025
The S&P 500 Has Returned an Average of 12.2% Annually Over the Past 10 Years. Here Is What History Says May Happen Over the Next Decadefool.com
A potential wild card is on the horizon.
Via The Motley Fool · May 14, 2025
Will Palantir Stock Join The $1 Trillion Market Cap Club by 2030? The Answer May Surprise You.fool.com
Investors are bullish on this AI defense contractor. The numbers tell a different story.
Via The Motley Fool · May 14, 2025
Latin America's Biggest E-Commerce Platform Is Growing Fast and Shows No Signs of Slowing Downfool.com
Via The Motley Fool · May 14, 2025
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Termfool.com
Via The Motley Fool · May 14, 2025
Is Krispy Kreme Stock a Buy, Sell, or Hold in 2025?fool.com
Via The Motley Fool · May 14, 2025
3 Warren Buffett-Type Stocks to Buy and Hold for Yearsfool.com
Via The Motley Fool · May 14, 2025
FUTU HOLDINGS LTD-ADR (NASDAQ:FUTU) - A Strong Growth Stock with Reasonable Valuationchartmill.com
FUTU HOLDINGS LTD-ADR (NASDAQ:FUTU) offers strong growth, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking growth at a sensible price.
Via Chartmill · May 14, 2025
Stocks Soar After U.S. and China Tariff Talks. Here's What Investors Need to Know Now.fool.com
Via The Motley Fool · May 14, 2025
Elliott Wave Technical Analysis S&P BSE Sensex - Wednesday, May 14talkmarkets.com
The daily chart signals a bullish trend for the S&P BSE Sensex, characterized by a strong impulsive structure.
Via Talk Markets · May 14, 2025
Here Are My Top 2 High-Yield Energy Stocks to Buy Nowfool.com
Via The Motley Fool · May 14, 2025
3 Top Tech Stocks That Could Make You a Millionairefool.com
Via The Motley Fool · May 14, 2025
1 Stock-Split AI Stock Up 2,330% Since 2015 to Buy Now, According to Wall Streetfool.com
Via The Motley Fool · May 14, 2025
RTX CORP (NYSE:RTX) – A Strong Technical Setup in Aerospace & Defensechartmill.com
RTX CORP (NYSE:RTX) shows strong technicals and a promising breakout setup, supported by upward trends and consolidation near resistance. A potential entry point exists above $133.00.
Via Chartmill · May 14, 2025
Meet Wall Street's Most Prolific Stock-Split Stock Throughout History -- a Company Whose Shares Have Gained Nearly 337,000% in 52 Yearsfool.com
This brand-name business has split its stock a staggering 14 times in less than 50 years.
Via The Motley Fool · May 14, 2025
Could This Potential Social Security Change Force You to Work Longer?fool.com
Via The Motley Fool · May 14, 2025
Elon Musk Says Mohammed Bin Salman And Trump Were 'Impressed' With Tesla Optimus As The Humanoid Robot Danced To 'YMCA'benzinga.com
Tesla Inc. CEO Elon Musk revealed that both Saudi Crown Prince Mohammed bin Salman and former U.S. President Donald Trump were impressed by the company's Optimus humanoid robot during a demonstration in Riyadh where the robot danced to "YMCA."
Via Benzinga · May 14, 2025
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) – An Undervalued Biotech Stock Worth Watchingchartmill.com
BIOMARIN PHARMACEUTICAL (NASDAQ:BMRN) is an undervalued biotech stock with strong profitability, solid financial health, and reasonable growth prospects, making it a candidate for value investors.
Via Chartmill · May 14, 2025
Earnings Scheduled For May 14, 2025benzinga.com
Via Benzinga · May 14, 2025